- /
- Supported exchanges /
- KO /
- 000020.KO
Dongwha Pharm.Co.Ltd (000020 KO) stock market data APIs
Dongwha Pharm.Co.Ltd Financial Data Overview
Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics. The company also exports its products. Dongwha Pharm.Co.,Ltd was founded in 1897 and is headquartered in Seoul, South Korea.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Dongwha Pharm.Co.Ltd data using free add-ons & libraries
Get Dongwha Pharm.Co.Ltd Fundamental Data
Dongwha Pharm.Co.Ltd Fundamental data includes:
- Net Revenue: 405 746 M
- EBITDA: 28 119 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-11-13
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Dongwha Pharm.Co.Ltd News
AdvanceTC Limited Releases Investor Guide with Q&A
Maker of World's First Multi-Mode Smartphones Details Tech Roadmap and Commercial Plan NEW YORK, NY, May 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ AdvanceTC Limited, (NSX:A88)(OTCQB:ATCLF) th...
AdvanceTC Limited Releases Investor Guide with Q&A
Maker of World's First Multi-Mode Smartphones Details Tech Roadmap and Commercial Plan NEW YORK, NY, May 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ AdvanceTC Limited, (NSX:A88)(OTCQB:ATCLF) th...
DongWha Pharm’s DW2008 Shows Excellent Antiviral Activity Against COVID-19
- Preparing for phase 2 clinical trials DongWha Pharm (KRX:000020), a leading Korean pharmaceutical company, announced on April 21st, 2020 that it plans to conduct clinical trials using a new drug ca...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.